Recent Updates
Recently added Catalysts

Treatment of Aortic Wall Injury

Phase 2

Aortic Coarctation | Unknown | Cardiovascular |Harvard Bioscience, Inc.|Last Updated: Apr 11, 2023

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
UNCONTROLLEDDMCBiomarker
Total Trials1
Total Enrollment82
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT01278303Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the AortaPHASE2 COMPLETED 82Jul 1, 2010Dec 1, 2014Apr 11, 202319 United States
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Study Participants With Grade 4 or 5 in Degree of Aortic Wall Injury (AWI) and/or Aortic Arch Obstruction Without Clinical Worsening
Baseline and 12 months

Severity of Illness Scale (SIS) improvement increase of at least 1 grade from baseline to 12 month follow-up SIS is divided into 3 conditions \& 5 grades of severity: 1 = worst (reserved for AWI) , 5 = best) C1 Upper Extremity Systolic Blood Pressure (SBP) 2- \> 159 mmHg or any hpn on \>2 medications 3- 140-159 mmHg or elevated SBP on \>2 medications 4- 130-139 mmHg or normal SBP on \>2 medications 5- \<130 mmHg on 0-2 meds C2 Upper Extremity to Lower Extremity SBP difference 2- \>59 mmHg 3- 30-59 mmHg 4- 15-29 mmHg 5- \<15 mmHg C3 Aortic Wall Injury severity levels: 1. Uncontained rupture or large aneurysm 2. Contained rupture or stable large aneurysm 3. Small contained rupture or moderate aneurysm 4. Acute, but stable AWI or small aneurysm 5. No injury or minor aortic wall irregularity not in need of treatment. * Grades for conditions represent comparable degrees of illness (0 worst, 5 best) -Grade 0 denotes death related to coarctation or study therapy

Secondary Endpoints
Secondary Efficacy Outcomes - 1 Year
1 years
Secondary Safety Outcomes - Adverse Events
2 years
Unlock Study Endpoints
Study Design & Arms
AllocationNA
MaskingNONE
ModelSINGLE_GROUP
PurposeTREATMENT
Treatment Arms
ArmTypeDescription
Treatment of Aortic Wall InjuryOTHERRepair of aortic wall injury with covered CP Stents
Interventions
NameTypeDescription
Treatment of Aortic Wall InjuryDEVICEA Cheatham covered platinum stent will be implanted in the Descending aorta to repair coarctation of the aorta in qualified patients.
Unlock Study Design Details
Eligibility Criteria
SexALL
Healthy VolunteersNo
Study Sites19

Inclusion Criteria: Inclusion criteria for use of a Covered CP Stent: Native or recurrent aortic coarctation\* associated with ONE OR MORE of the following: 1. Acute or chronic aortic wall injury, or 2. Nearly atretic descending aorta to 3 mm or less in diameter, or 3. Genetic Syndromes associated...

Countries:United States
Unlock Eligibility Criteria